Literature DB >> 24969118

Increased levels of serum neopterin in attention deficit/hyperactivity disorder (ADHD).

Mehmet Fatih Ceylan1, Ozden Sukran Uneri2, Esra Guney2, Merve Ergin3, Murat Alisik3, Zeynep Goker2, Gulser Senses Dinc2, Fatma Karaca Kara4, Ozcan Erel3.   

Abstract

Attention deficit/hyperactivity disorder (ADHD) is the most frequently occurring neuropsychiatric disorder in childhood with an etiology that is not fully understood. A number of reviews that have addressed the neurobiology of ADHD have focused on imaging and genetics. Relatively little attention has been given to factors/mechanisms involved in the brain dysfunction. We suggest that changes in cellular immunity may be involved. Neopterin is a good indicator of cellular immunity, and we evaluated serum levels of neopterin in patients with ADHD. The study group consisted of 49 patients with ADHD. An age- and gender-matched control group was composed of 31 healthy subjects. Venous blood samples were collected, and the levels of neopterin were measured. The levels of neopterin were significantly higher in ADHD than in the comparison subjects. Cellular immunity may have a role in the etiopathogenesis of ADHD.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ADHD; Attention deficit/hyperactivity disorder; Cellular immunity; Neopterin

Mesh:

Substances:

Year:  2014        PMID: 24969118     DOI: 10.1016/j.jneuroim.2014.06.002

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

1.  Seasonality of blood neopterin levels in the Old Order Amish.

Authors:  Hira Mohyuddin; Polymnia Georgiou; Abhishek Wadhawan; Melanie L Daue; Lisa A Brenner; Claudia Gragnoli; Erika F H Saunders; Dietmar Fuchs; Christopher A Lowry; Teodor T Postolache
Journal:  Pteridines       Date:  2017-12-02       Impact factor: 0.581

2.  Externalizing trajectories predict elevated inflammation among adolescents exposed to early institutional rearing: A randomized clinical trial.

Authors:  Alva Tang; Nathan A Fox; Charles A Nelson; Charles H Zeanah; Natalie Slopen
Journal:  Psychoneuroendocrinology       Date:  2019-08-13       Impact factor: 4.905

Review 3.  Gut microbiota and attention deficit hyperactivity disorder: new perspectives for a challenging condition.

Authors:  María Carmen Cenit; Isabel Campillo Nuevo; Pilar Codoñer-Franch; Timothy G Dinan; Yolanda Sanz
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-03-13       Impact factor: 4.785

4.  High monocyte level and low lymphocyte to monocyte ratio in autism spectrum disorders.

Authors:  Selma Tural Hesapcioglu; Meryem Kasak; Aysegül Nese Cıtak Kurt; Mehmet Fatih Ceylan
Journal:  Int J Dev Disabil       Date:  2017-09-26

5.  Role of maternal health and infant inflammation in nutritional and neurodevelopmental outcomes of two-year-old Bangladeshi children.

Authors:  Jeffrey R Donowitz; Heather Cook; Masud Alam; Fahmida Tofail; Mamun Kabir; E Ross Colgate; Marya P Carmolli; Beth D Kirkpatrick; Charles A Nelson; Jennie Z Ma; Rashidul Haque; William A Petri
Journal:  PLoS Negl Trop Dis       Date:  2018-05-29

6.  Increased Serum Level of CCL5 in Children with Attention‑Deficit/Hyperactivity Disorder: First Results about Serum Chemokines.

Authors:  Ahmet Özaslan; Esra Güney; Özlem Gülbahar; Dicle Büyüktaskin; Burak Arslan
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-02-28       Impact factor: 2.582

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.